Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients

Livio Luzi, Leif C. Groop, Gianluca Perseghin, Marja Riitta Taskinen, Hannele Hilden, Elda Bianchi, Ileana Terruzzi, Alessandro R. Dodesini, Valerio Di Carlo, Guido Pozza

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

To assess the effect of pancreas transplantation on free fatty acid (FFA) and glucose metabolism, we studied seven uremic IDDM patients (HbA(1c) 9.1%), nine IDDM patients after combined kidney-pancreas transplantation (HbA(1c) 5.8%), seven patients with chronic uveitis (HbA(1c) 5.6%), and nine normal control subjects (HbA(1c) 5.5%) by means of the [3-3H]glucose and [1- 14C]palmitate infusion techniques combined with indirect calorimetry and euglycemic insulin clamp. In the postabsorptive state, pancreas-transplant patients had similar plasma glucose and FFA concentrations and non- statistically different rates of hepatic glucose production (HGP) and FFA turnover, while demonstrating a reduced rate of FFA oxidation (42 ± 5 vs. 73 ± 10 μmol · m-2 · min-1; P <0.05) compared with control subjects. After 180 min of tracer equilibration, all subjects underwent a low-dose (100 min, 8 mU · m-2 · min-1) followed by a high-dose (100 min, 40 mU · m- 2 · min-1) euglycemic insulin infusion. During insulin infusion, pancreas-transplant patients showed a greater inhibition of FFA concentration (609 ± 76 to 58 ± 15 μmol/l) compared with healthy subjects (681 ± 90 to 187 ± 25 μmol/l; P <0.01 vs. pancreas-transplant patients). FFA turnover and oxidation rates during both low-dose and high-dose insulin infusions were lower in pancreas-transplant patients compared with healthy subjects (P <0.03 and P <0.01, for turnover and oxidation, respectively). Uremic IDDM patients demonstrated altered basal and insulin-mediated glucose metabolism. Pancreas transplantation normalized only insulin-mediated glucose oxidation, leaving the stimulation of nonoxidative glucose disposal still markedly defective. In conclusion, patients after pancreas transplantation have normal basal FFA turnover and reduced basal FFA oxidation rates. During hyperinsulinemia, pancreas-transplant patients show a normal inhibition of FFA turnover and FFA oxidation. Insulin-mediated glucose metabolism remained abnormal after pancreas transplantation. Our findings may be related to the effect of chronic immunosuppressive therapy on glucose and FFA metabolism.

Original languageEnglish
Pages (from-to)354-360
Number of pages7
JournalDiabetes
Volume45
Issue number3
Publication statusPublished - 1996

Fingerprint

Pancreas Transplantation
Type 1 Diabetes Mellitus
Nonesterified Fatty Acids
Glucose
Insulin
Pancreas
Transplants
Healthy Volunteers
Indirect Calorimetry
Glucose Clamp Technique
Palmitates
Uveitis
Hyperinsulinism
Immunosuppressive Agents
Kidney Transplantation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Luzi, L., Groop, L. C., Perseghin, G., Taskinen, M. R., Hilden, H., Bianchi, E., ... Pozza, G. (1996). Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients. Diabetes, 45(3), 354-360.

Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients. / Luzi, Livio; Groop, Leif C.; Perseghin, Gianluca; Taskinen, Marja Riitta; Hilden, Hannele; Bianchi, Elda; Terruzzi, Ileana; Dodesini, Alessandro R.; Di Carlo, Valerio; Pozza, Guido.

In: Diabetes, Vol. 45, No. 3, 1996, p. 354-360.

Research output: Contribution to journalArticle

Luzi, L, Groop, LC, Perseghin, G, Taskinen, MR, Hilden, H, Bianchi, E, Terruzzi, I, Dodesini, AR, Di Carlo, V & Pozza, G 1996, 'Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients', Diabetes, vol. 45, no. 3, pp. 354-360.
Luzi L, Groop LC, Perseghin G, Taskinen MR, Hilden H, Bianchi E et al. Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients. Diabetes. 1996;45(3):354-360.
Luzi, Livio ; Groop, Leif C. ; Perseghin, Gianluca ; Taskinen, Marja Riitta ; Hilden, Hannele ; Bianchi, Elda ; Terruzzi, Ileana ; Dodesini, Alessandro R. ; Di Carlo, Valerio ; Pozza, Guido. / Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients. In: Diabetes. 1996 ; Vol. 45, No. 3. pp. 354-360.
@article{dc7e2d9c18e44fffac7e49679f978600,
title = "Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients",
abstract = "To assess the effect of pancreas transplantation on free fatty acid (FFA) and glucose metabolism, we studied seven uremic IDDM patients (HbA(1c) 9.1{\%}), nine IDDM patients after combined kidney-pancreas transplantation (HbA(1c) 5.8{\%}), seven patients with chronic uveitis (HbA(1c) 5.6{\%}), and nine normal control subjects (HbA(1c) 5.5{\%}) by means of the [3-3H]glucose and [1- 14C]palmitate infusion techniques combined with indirect calorimetry and euglycemic insulin clamp. In the postabsorptive state, pancreas-transplant patients had similar plasma glucose and FFA concentrations and non- statistically different rates of hepatic glucose production (HGP) and FFA turnover, while demonstrating a reduced rate of FFA oxidation (42 ± 5 vs. 73 ± 10 μmol · m-2 · min-1; P <0.05) compared with control subjects. After 180 min of tracer equilibration, all subjects underwent a low-dose (100 min, 8 mU · m-2 · min-1) followed by a high-dose (100 min, 40 mU · m- 2 · min-1) euglycemic insulin infusion. During insulin infusion, pancreas-transplant patients showed a greater inhibition of FFA concentration (609 ± 76 to 58 ± 15 μmol/l) compared with healthy subjects (681 ± 90 to 187 ± 25 μmol/l; P <0.01 vs. pancreas-transplant patients). FFA turnover and oxidation rates during both low-dose and high-dose insulin infusions were lower in pancreas-transplant patients compared with healthy subjects (P <0.03 and P <0.01, for turnover and oxidation, respectively). Uremic IDDM patients demonstrated altered basal and insulin-mediated glucose metabolism. Pancreas transplantation normalized only insulin-mediated glucose oxidation, leaving the stimulation of nonoxidative glucose disposal still markedly defective. In conclusion, patients after pancreas transplantation have normal basal FFA turnover and reduced basal FFA oxidation rates. During hyperinsulinemia, pancreas-transplant patients show a normal inhibition of FFA turnover and FFA oxidation. Insulin-mediated glucose metabolism remained abnormal after pancreas transplantation. Our findings may be related to the effect of chronic immunosuppressive therapy on glucose and FFA metabolism.",
author = "Livio Luzi and Groop, {Leif C.} and Gianluca Perseghin and Taskinen, {Marja Riitta} and Hannele Hilden and Elda Bianchi and Ileana Terruzzi and Dodesini, {Alessandro R.} and {Di Carlo}, Valerio and Guido Pozza",
year = "1996",
language = "English",
volume = "45",
pages = "354--360",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients

AU - Luzi, Livio

AU - Groop, Leif C.

AU - Perseghin, Gianluca

AU - Taskinen, Marja Riitta

AU - Hilden, Hannele

AU - Bianchi, Elda

AU - Terruzzi, Ileana

AU - Dodesini, Alessandro R.

AU - Di Carlo, Valerio

AU - Pozza, Guido

PY - 1996

Y1 - 1996

N2 - To assess the effect of pancreas transplantation on free fatty acid (FFA) and glucose metabolism, we studied seven uremic IDDM patients (HbA(1c) 9.1%), nine IDDM patients after combined kidney-pancreas transplantation (HbA(1c) 5.8%), seven patients with chronic uveitis (HbA(1c) 5.6%), and nine normal control subjects (HbA(1c) 5.5%) by means of the [3-3H]glucose and [1- 14C]palmitate infusion techniques combined with indirect calorimetry and euglycemic insulin clamp. In the postabsorptive state, pancreas-transplant patients had similar plasma glucose and FFA concentrations and non- statistically different rates of hepatic glucose production (HGP) and FFA turnover, while demonstrating a reduced rate of FFA oxidation (42 ± 5 vs. 73 ± 10 μmol · m-2 · min-1; P <0.05) compared with control subjects. After 180 min of tracer equilibration, all subjects underwent a low-dose (100 min, 8 mU · m-2 · min-1) followed by a high-dose (100 min, 40 mU · m- 2 · min-1) euglycemic insulin infusion. During insulin infusion, pancreas-transplant patients showed a greater inhibition of FFA concentration (609 ± 76 to 58 ± 15 μmol/l) compared with healthy subjects (681 ± 90 to 187 ± 25 μmol/l; P <0.01 vs. pancreas-transplant patients). FFA turnover and oxidation rates during both low-dose and high-dose insulin infusions were lower in pancreas-transplant patients compared with healthy subjects (P <0.03 and P <0.01, for turnover and oxidation, respectively). Uremic IDDM patients demonstrated altered basal and insulin-mediated glucose metabolism. Pancreas transplantation normalized only insulin-mediated glucose oxidation, leaving the stimulation of nonoxidative glucose disposal still markedly defective. In conclusion, patients after pancreas transplantation have normal basal FFA turnover and reduced basal FFA oxidation rates. During hyperinsulinemia, pancreas-transplant patients show a normal inhibition of FFA turnover and FFA oxidation. Insulin-mediated glucose metabolism remained abnormal after pancreas transplantation. Our findings may be related to the effect of chronic immunosuppressive therapy on glucose and FFA metabolism.

AB - To assess the effect of pancreas transplantation on free fatty acid (FFA) and glucose metabolism, we studied seven uremic IDDM patients (HbA(1c) 9.1%), nine IDDM patients after combined kidney-pancreas transplantation (HbA(1c) 5.8%), seven patients with chronic uveitis (HbA(1c) 5.6%), and nine normal control subjects (HbA(1c) 5.5%) by means of the [3-3H]glucose and [1- 14C]palmitate infusion techniques combined with indirect calorimetry and euglycemic insulin clamp. In the postabsorptive state, pancreas-transplant patients had similar plasma glucose and FFA concentrations and non- statistically different rates of hepatic glucose production (HGP) and FFA turnover, while demonstrating a reduced rate of FFA oxidation (42 ± 5 vs. 73 ± 10 μmol · m-2 · min-1; P <0.05) compared with control subjects. After 180 min of tracer equilibration, all subjects underwent a low-dose (100 min, 8 mU · m-2 · min-1) followed by a high-dose (100 min, 40 mU · m- 2 · min-1) euglycemic insulin infusion. During insulin infusion, pancreas-transplant patients showed a greater inhibition of FFA concentration (609 ± 76 to 58 ± 15 μmol/l) compared with healthy subjects (681 ± 90 to 187 ± 25 μmol/l; P <0.01 vs. pancreas-transplant patients). FFA turnover and oxidation rates during both low-dose and high-dose insulin infusions were lower in pancreas-transplant patients compared with healthy subjects (P <0.03 and P <0.01, for turnover and oxidation, respectively). Uremic IDDM patients demonstrated altered basal and insulin-mediated glucose metabolism. Pancreas transplantation normalized only insulin-mediated glucose oxidation, leaving the stimulation of nonoxidative glucose disposal still markedly defective. In conclusion, patients after pancreas transplantation have normal basal FFA turnover and reduced basal FFA oxidation rates. During hyperinsulinemia, pancreas-transplant patients show a normal inhibition of FFA turnover and FFA oxidation. Insulin-mediated glucose metabolism remained abnormal after pancreas transplantation. Our findings may be related to the effect of chronic immunosuppressive therapy on glucose and FFA metabolism.

UR - http://www.scopus.com/inward/record.url?scp=13344282060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13344282060&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 354

EP - 360

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 3

ER -